We are live on ! Find out more
IHI icon

iShares US Medical Devices ETF

574 hedge funds and large institutions have $2.36B invested in iShares US Medical Devices ETF in 2023 Q4 according to their latest regulatory filings, with 94 funds opening new positions, 138 increasing their positions, 245 reducing their positions, and 56 closing their positions.

New
Increased
Maintained
Reduced
Closed

111% more call options, than puts

Call options by funds: $43M | Put options by funds: $20.4M

68% more first-time investments, than exits

New positions opened: 94 | Existing positions closed: 56

18% more capital invested

Capital invested by funds: $2.01B → $2.36B (+$353M)

6% more funds holding

Funds holding: 544574 (+30)

4.42% more ownership

Funds ownership: 39.49%43.91% (+4.4%)

33% less funds holding in top 10

Funds holding in top 10: 96 (-3)

44% less repeat investments, than reductions

Existing positions increased: 138 | Existing positions reduced: 245

Holders
574
Holders Change
+30
Holders Change %
+5.51%
% of All Funds
8.37%
Holding in Top 10
6
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-33.33%
% of All Funds
0.09%
New
94
Increased
138
Reduced
245
Closed
56
Calls
$43M
Puts
$20.4M
Net Calls
+$22.6M
Net Calls Change
+$16.7M
Name Holding Trade Value Shares
Change
Change in
Stake
WAS
576
WESPAC Advisors SoCal
California
-$7.61M -156,920 Closed
SAS
577
Stelac Advisory Services
New York
-$5.14M -105,891 Closed
Two Sigma Advisers
578
Two Sigma Advisers
New York
-$4.6M -94,900 Closed
CAM
579
Concorde Asset Management
Michigan
-$4.21M -86,834 Closed
CF
580
Clarity Financial
Texas
-$3.36M -69,183 Closed
YIH
581
Y-Intercept (HK)
Hong Kong
-$2.25M -46,322 Closed
RHP
582
Royal Harbor Partners
Texas
-$2.1M -43,382 Closed
CWM
583
Concentrum Wealth Management
California
-$1.75M -36,076 Closed
GS
584
GTS Securities
New York
-$1.7M -34,706 Closed
CWM
585
C2C Wealth Management
Arizona
-$1.56M -32,454 Closed
YAVAPFMC
586
Yahav Achim Ve Achayot - Provident Funds Management Company
Israel
-$1.51M -30,555 Closed
FTUS
587
Flow Traders U.S.
New York
-$1.3M -26,907 Closed
QIM
588
Quantitative Investment Management
Virginia
-$1.23M -25,274 Closed
CA
589
Crumly & Associates
Illinois
-$1.16M -23,880 Closed
SAM
590
Strategy Asset Managers
California
-$1.04M -21,355 Closed
Balyasny Asset Management
591
Balyasny Asset Management
Illinois
-$954K -19,674 Closed
AIC
592
Ayalon Insurance Company
Israel
-$923K -18,991 Closed
SFS
593
Security Financial Services
Indiana
-$740K -15,263 Closed
TJHA
594
Thomas J. Herzfeld Advisors
Florida
-$729K -15,034 Closed
SG
595
StoneX Group
New York
-$635K -13,080 Closed
SCA
596
Southern Capital Advisors
Tennessee
-$586K -12,076 Closed
Wolverine Trading
597
Wolverine Trading
Illinois
-$515K -10,624 Closed
Two Sigma Investments
598
Two Sigma Investments
New York
-$461K -9,500 Closed
BSG
599
Black Swift Group
Colorado
-$441K -9,100 Closed
TSS
600
Two Sigma Securities
New York
-$351K -7,232 Closed

IHI Hedge Fund Activity: Q4 2023 in Review

574 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in iShares US Medical Devices ETF (IHI) for Q4 2023, worth a combined $2.36B — up 18% from $2.01B a quarter earlier.

Buyers outnumbered sellers: 94 funds opened new IHI positions and 56 closed out — a net gain of 38 holders — while 138 added to existing stakes and 245 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $159M. The largest seller was Bank of America, cutting an estimated $25.1M.

  • 574 institutional investors held iShares US Medical Devices ETF (IHI) as of Q4 2023, up from 544 in Q3 2023.
  • Funds reported $2.36B of iShares US Medical Devices ETF stock for Q4 2023, up 18% quarter-over-quarter.
  • 94 funds opened new iShares US Medical Devices ETF positions in Q4 2023 and 56 closed out, a net change of +38 holders.
  • The largest iShares US Medical Devices ETF buyer in Q4 2023 was Morgan Stanley, an estimated $159M added.
  • The largest iShares US Medical Devices ETF seller in Q4 2023 was Bank of America, an estimated $25.1M sold.

Based on aggregated 13F filings for Q4 2023.